Cargando…

Radiotherapy combined with hormonal therapy in prostate cancer: the state of the art

Androgen-deprivation therapy (ADT) is used routinely in combination with definitive external beam radiation therapy (EBRT) in patients with high-risk clinically localized or locally advanced disease. The combined treatment (ADT–EBRT) also seems to play a significant role in improving treatment resul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milecki, Piotr, Martenka, Piotr, Antczak, Andrzej, Kwias, Zbigniew
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004567/ https://www.ncbi.nlm.nih.gov/pubmed/21188116 http://dx.doi.org/10.2147/CMR.S8912

Ejemplares similares

Hormone therapy in combination with radiotherapy in the treatment of prostate cancer: why and in which group of patients?
por: Milecki, Tomasz, et al.
Publicado: (2015)

What is the possible role of PSA doubling time (PSADT) and PSA velocity (PSAV) in the decision-making process to initiate salvage radiotherapy following radical prostatectomy in patients with prostate cancer?
por: Milecki, Piotr, et al.
Publicado: (2011)

Benefit of Whole Pelvic Radiotherapy Combined with Neoadjuvant Androgen Deprivation for the High-Risk Prostate Cancer
por: Milecki, Piotr, et al.
Publicado: (2009)

The use of luteinizing hormone-releasing hormone analogues is still an indispensable element of therapy in castrate-resistant prostate cancer
por: Milecki, Tomasz, et al.
Publicado: (2014)

Polish Medical Students’ Knowledge Regarding Human Papillomavirus’s Ways of Transmission, Risk of Cancer Development and Vaccination, and Their Intention to Recommend Vaccination
por: Milecki, Tomasz, et al.
Publicado: (2021)

Future Perspectives of Proton Therapy in Minimizing the Toxicity of Breast Cancer Radiotherapy
por: Musielak, Marika, et al.
Publicado: (2021)

FLASH radiotherapy: an emerging approach in radiation therapy
por: Matuszak, Natalia, et al.
Publicado: (2022)

Radiation-induced lung injury — what do we know in the era of modern radiotherapy?
por: Konkol, Marek, et al.
Publicado: (2022)

Evidence-based recommendations on androgen deprivation therapy for localized and advanced prostate cancer
por: Golabek, Tomasz, et al.
Publicado: (2016)

Urology resident training in laparoscopic surgery – results of the first national survey in Poland
por: Brzoszczyk, Bartosz, et al.
Publicado: (2019)

Large Prostate Volume Does Not Negatively Impact Health-Related Quality of Life in Patients with Prostate Cancer Treated with Ultrahypofractionated Stereotactic Body Radiotherapy
por: Milecki, Piotr, et al.
Publicado: (2023)

Radiotherapy planning in a prostate cancer phantom model with intraprostatic dominant lesions using stereotactic body radiotherapy with volumetric modulated arcs and a simultaneous integrated boost
por: Skrobala, Agnieszka, et al.
Publicado: (2023)

MR-guided radiotherapy for prostate cancer: state of the art and future perspectives
por: Sritharan, Kobika, et al.
Publicado: (2022)

Baseline CTC Count as a Predictor of Long-Term Outcomes in High-Risk Prostate Cancer
por: Cieślikowski, Wojciech A., et al.
Publicado: (2023)

The use of hormonal therapy with radiotherapy for prostate cancer: analysis of prospective randomised trials
por: Gottschalk, A R, et al.
Publicado: (2004)

Reasons behind the Delayed Diagnosis of Testicular Cancer: A Retrospective Analysis
por: Cieślikowski, Wojciech A., et al.
Publicado: (2023)

Exercise tolerance in breast cancer patients during radiotherapy after aerobic training
por: Milecki, Piotr, et al.
Publicado: (2013)

Editorial to the Special Issue on Skin Cancer: The State of the Art
por: Rutkowski, Piotr, et al.
Publicado: (2022)

Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer
por: Cieślikowski, Wojciech A., et al.
Publicado: (2020)

Analysis of the usefulness of magnetic resonance imaging and clinical parameters in the detection of prostate cancer in the first systematic biopsy combined with targeted cognitive biopsy
por: Majchrzak, Natalia, et al.
Publicado: (2021)

Dosimetric Comparison of Ultra-Hypofractionated and Conventionally Fractionated Radiation Therapy Boosts for Patients with High-Risk Prostate Cancer
por: Piotrowski, Tomasz, et al.
Publicado: (2022)

Normal Lung Tissue CT Density Changes after Volumetric-Arc Radiotherapy (VMAT) for Lung Cancer
por: Konkol, Marek, et al.
Publicado: (2022)

State of the Art in Combination Immuno/Radiotherapy for Brain Metastases: Systematic Review and Meta-Analysis
por: Najafi, Masoumeh, et al.
Publicado: (2022)

WHO SHOULD RECEIVE RADIOTHERAPY IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCER?
por: Bišof, Vesna
Publicado: (2019)

The role of postoperative radiotherapy in prostate cancer patients
por: Zarzycka, Małgorzata, et al.
Publicado: (2013)

Ultra-Hypofractionated Proton Therapy in Localized Prostate Cancer: Passive Scattering versus Intensity-Modulated Proton Therapy
por: Borowicz, Dorota Maria, et al.
Publicado: (2021)

Identification of RCC Subtype-Specific microRNAs–Meta-Analysis of High-Throughput RCC Tumor microRNA Expression Data
por: Kajdasz, Arkadiusz, et al.
Publicado: (2021)

Factors influencing quality of life in patients during radiotherapy for head and neck cancer
por: Żmijewska-Tomczak, Małgorzata, et al.
Publicado: (2013)

State-of-the-art Prostate Imaging
por: Ayyildiz, Hakan, et al.
Publicado: (2023)

In utero surgery – current state of the art – part II
por: Wójcicki, Piotr, et al.
Publicado: (2011)

3D Printing in Heterogeneous Catalysis—The State of the Art
por: Bogdan, Elżbieta, et al.
Publicado: (2020)

Proton beam radiotherapy for esophagus cancer: state of the art
por: Gergelis, Kimberly R., et al.
Publicado: (2020)

Multimodal therapy for locally advanced prostate cancer: the roles of radiotherapy, androgen deprivation therapy, and their combination
por: Lee, Sung Uk, et al.
Publicado: (2017)

Predictions of cancer incidence in Wielkopolska in 2018
por: Godlewski, Dariusz, et al.
Publicado: (2012)

Learning radiotherapy: the state of the art
por: Walls, Gerard M., et al.
Publicado: (2020)

Combination therapy with androgen deprivation for hormone sensitive prostate cancer: A new frontier
por: Etheridge, Tyler, et al.
Publicado: (2019)

The State of the Art of Theranostic Nanomaterials for Lung, Breast, and Prostate Cancers
por: Freitas, Lucas F., et al.
Publicado: (2021)

Immunotherapy in Prostate Cancer: State of Art and New Therapeutic Perspectives
por: Maselli, Felicia Maria, et al.
Publicado: (2023)

Autoantibodies in Atrial Fibrillation—State of the Art
por: Zygadło, Joanna, et al.
Publicado: (2023)

Prostate radiotherapy for metastatic hormone sensitive prostate cancer—myth or reality?
por: Onal, Cem
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k9kjgkq8jrqd6fstkqde21q2ct